We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to... Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings. Show more
The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury...
The Swoop® Portable MR Imaging® system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke care Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the...
─ Reports $3.6M in Q2 2024 Revenue; 50% Gross Margin─ Raises FY 2024 Revenue Guidance to $13-16M GUILFORD, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the...
Two poster presentations at AAIC provide early evidence of the value of ultra-low-field Swoop® system MR brain images in ARIA-E detection and morphography evaluation in patients with Alzheimer's...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -1.9801980198 | 1.01 | 1.05 | 0.97 | 56170 | 1.00250986 | CS |
4 | -0.01 | -1 | 1 | 1.08 | 0.96 | 72187 | 1.02850125 | CS |
12 | -0.25 | -20.1612903226 | 1.24 | 1.26 | 0.8516 | 110607 | 1.06276256 | CS |
26 | -0.04 | -3.88349514563 | 1.03 | 1.266 | 0.7613 | 119423 | 1.00533794 | CS |
52 | -1.01 | -50.5 | 2 | 2.07 | 0.7613 | 113418 | 1.09602959 | CS |
156 | -10.8401 | -91.6315162171 | 11.8301 | 16.61 | 0.68 | 312462 | 1.79453547 | CS |
260 | -10.8401 | -91.6315162171 | 11.8301 | 16.61 | 0.68 | 312462 | 1.79453547 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions